Liver transplantation in viral hepatitis. New insights

Acta Gastro-Enterologica Belgica

Volumn 62, Issue 3, 1999, Pages 342-347

  Marzano, Alfredo ^a,b   Salizzoni, M ^a   Rizzetto, M ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c NONE

Author keywords

Antivirals; Immunoprophylaxis; Liver transplantation; Viral hepatitis

Indexed keywords

ADEFOVIR DIPIVOXIL; AMINOTRANSFERASE; ANTIVIRUS AGENT; ARABINOSIDE; FAMCICLOVIR; GANCICLOVIR; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B(E) ANTIGEN; HUMAN ALBUMIN; INTERFERON; LAMIVUDINE; NUCLEOSIDE DERIVATIVE; RIBAVIRIN; VIRUS DNA;

CONFERENCE PAPER; DELTA AGENT HEPATITIS; GENE MUTATION; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNOPROPHYLAXIS; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MORBIDITY; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENT DISEASE; REINFECTION; SURVIVAL; VIRUS HEPATITIS; VIRUS LOAD;

HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; PROGNOSIS; RECURRENCE; RISK FACTORS; VIREMIA;

EID: 0032850558     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (58)

1. DETRE K. Liver transplantation for chronic viral hepatitis. Viral Hepatitis Reviews, 1996, 2 : 219-228.
2. SAMUEL D. Liver transplantation for viral hepatitis : the experience of the hepatobiliry center at Hospital Paul Brousse. In : TERASAKI P.I., CECKA J.M. (eds). Clinical Transplantas 1994, UCLA Tisue Typing Laboratory. Los Angeles, California 157-162.
3. TODO S., DEMETRIS A.J., VAN THIEL D., TAPERMAN L., FUNG J., STARZL T.E. Orthotopic liver transplantation for patients with hepatitis B related liver disease. Hepatology, 1991, 13 : 619-626.
4. DAVIES S.E., PORTMANN B.C., O'GRADY J.G., ALDIS P.M., CHAGGAR K., ALEXANDER G.J.M., WILLIAMS R. Hepatic histologic finding after transplantation for chronic hepatitis B virus infection : including a unique pattern of fibrosing cholestatic hepatitis, Hepatology, 1991, 13 : 150-157.
5. CRIPPIN J., FORSTER B., CARLEN S., BORCHIC A., BODENHEIMER H. Retransplantation in hepatitis B-A multicenter experience. Transplantation, 1994, 57 : 823-826.
6. SAMUEL D., MULLER R., ALEXANDER G., FASSATI L., DUCOT B., BENHAMOU J.P. Liver transplantation in European patients with the hepatitis B surface antigen. N. Engl. J. Med. 1993, 329 : 1842-1847.
7. LAUCHART W., MULLER R., PICHLMAYER R. Long-term immunoprophylaxis of hepatitis B virus (HBV) reinfection in recipients of human liver allografts. Transplant. Proc., 1987, 19 : 4051-4053.
8. SAMUEL D., BISMUTH A., MATHIEU D., ARUNALDEN J.L., REYNES M., BENHAMOU J.P., BRECHOT C., BISMUTH H. Passive immunoprophylaxis after liver transplantation in HBsAg-positive. Lancet, 1991, 337 : 813-815.
9. MARZANO A., CARUCCI P., DEBERNARDI-VENON W., TORRANI M., CAPRA G., BONINO F., RIZZETTO M., VERME G. HBV-DNA by PCR like prognostic indicator of recurrence rate in HBeAg patients undergoing liver transplant. Ital. J. Gastroenterol., 1994 (S2), 26 : 107.
10. MARZANO A., DEBERNARDI-VENON W., SMEDILE A., BRUNETTO M.R., TORRANI-CERENZIA M.R., ACTIS G.C., ZAMBONI F., GHISETTI V., PIANTINO P., DAVID E., SALIZZONI M., RIZZETTO M. Recurrence of hepatitis B in liver transplants treated with antiviral therapy. Ital. J. Gastroenterol. Hepatol., 1998, 1998, 30 : 77-81.
11. MÜLLER R., SAMUEL D., FASSATI L., DUCOT B., BENHAMOU J.P., BISMUTH H., ALEXANDER G.J.M. "EUROHEP" consensus report on the management of liver transplantation for hepatitis B infection. J. Hepatol., 1994, 21 : 1140-1143.
12. JOHNSON P.J. Liver transplantation in carriers of the HBsAg: role of short-term passive prophylaxis with immunoglobulin. J. Hepatol., 1992, 14 : 411.
13. SAMUEL D., FERAY H., BISMUTH H. Risk of viral reinfection after liver transplantation. In : RIZZETTO M., PURCELL R.H., GERIN J.E., VERME G. (Eds). Viral hepatitis and liver disease ; Minerva Medica, Turin 1997, 832-34.
14. MÜLLER R., GUBERNATIS G., FARLE M., NIEHOFF G., KLEIN H., WITTEKIND C., TUSCH G., LAUTZ H.U., BOKER K., STANGEL W., PICHLMAYER R. Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J. Hepatol., 1991, 13 : 90-96.
15. BURBACH G.J., BIENZLE U., NEUHAUS R., HOPF U., METZGER W.G., PRATSCHKE J., NEUHAUS P. Intravenous or intramuscolar anti-HBs immunoglobulin for the prevention of hepatitis B reinfection after orthotopic liver transplantation. Transplantation, 1997, 63 : 478-480.
16. KÖNIG V., HOPF U., NEUHAUS P., BAUDITZ J., SCHMIDT C.A., BLUMHARDT G., BECHSTEIN W.O., NEUHAUS R., LOBECK H. Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. Transplantation, 1994, 58 : 553.
17. ISHITANI M. Six month versus continued intermittent HBIG administration in the prevention of hepatitis B reinfection after liver tranplantation. Gastroenterology, 1991, 104 : 920.
18. MORA N.P., KLINTMALM G.B., POPLAWSKI S.S., COFER J.B., HUSBERG B.S., GONWA T.A., GOLDSTEIN R.M. Recurrence of hepatitis B after liver transplantation : does hepatitis B immunoglobulin modify the recurrent disease ? Transplant. Proc., 1990, 22 : 1547-1548.
19. WRIGHT T.L., ZELDIS J.B., MAMISH D. Graft infection with hepatitis B (HBV) following liver transplantation (OLTx) : prognostic importance of viral replication. Hepatology, 1990, 12 : 867.
20. TERRAULT N.A., ZHOU S., COMBS C., HAHN J.A., LAKE J.R., ROBERTS J.P., ASCHER N.L., WRIGHT T.L. Prophylaxis in liver transplant recipients using a fixing doseing schedule of hepatitis B immunoglobulin. Hepatology, 1996, 24 : 1327-1333.
21. BARUCH Y., BEN-PORATH E., ENAT R. Immunoprophylaxis with hepatitis B immunoglobulin after liver transplantation : an economical approach. J. Hepatol., 1994, 58 : 553.
22. MCGORY R.W., ISHITANI M., OLIVEIRA W.M., STEVENSON W.C., MC CULLOUGH C.S., DICKSON R.C., CALDWELL S.H., PRUETT T.L. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation, 1996, 61 : 1358-1664.
23. MC MAHON G., ELRICH P.H., MOUSTAFA Z.A., MC CARTHY L.A., DOTTAVIO D., TOLPIN M.D., NADLER P.I., OSTBERG L. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology, 1992, 15 : 757-766.
24. ÖSTBERG L., MCMAHON G., HARFELDT E., EHRLICH P.H. Elimination of hepatitis B virus by human monoclonal antibody therapy in HBsAg positive liver transplant recipients. In : RIZZETTO M., PURCELL R.H., GERIN J.L., VERME G. (Eds). Viral hepatitis and liver disease ; Minerva Medica, 1997, 832-34.
25. CARMAN W.F., TRAUTWEIN C., VANDEURSEN F.J., COLMAN K., DORNAN E., MCINTYRE G., WATERS J., KLIEM V., MULLER R., THOMAS H.C., MANNS M.P. Hepatitis B virus envelope variation after liver transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology, 1996, 24 : 489-493.
26. PROTZER-KNOLLE U., NAUMANN U., BARTENSCHLAGER R., BERG T., HOPF U., MEYER ZUM BUSCHENFELDE K.H., NEUHAUS P., GERKEN G. Hepatitis b virus antigenically altered hepatitis B surface antigen selected by high dose hepatitis B immune globulin after liver transplantation. Hepatology, 1998, 27 : 254-263.
27. LOCARNINI S. Hepatitis B virus surface antigen and polymerase gene variants : potential virological and clinical significance. Hepatology, 1998, 27 : 294-297.
28. MARCELLIN P., SAMUEL D., AREIAS J., LORIOT M.A., ARUNALDEN J.L., GIGOU M., DAVID M.F., BISMUIH A., REYNES M., BRECHOT C., BENHAMOU J.P., BISMUTH H. Pretransplantation interferon treatment and reccurent of hepatitis B virus infection after liver tranpslantation for hepatitis B related end stage liver disease. Hepatology, 1994, 19 : 6-12.
29. LOCARNINI S, GUO K., LUCAS R., GUST I. Inibition of HBV DNA replication by Ganciclovir in patients with AIDS. Lancet, 1989, 1225-1226.
30. FIUME L., BONINO F., MATTIOLI A., CHIABERGE E., TORRANICERENZIA M.R., BUSI C., BRUNETTO M.R. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugate with lactosaminated serum albumin. Lancet, 1988, 2 : 13-15.
31. GISH R.G., LAU J., BROOKS L., FANG J.W.S., STEADY S.L., IMPERIAL J.C., GARCIA-KENNEDY R., ESQUIVEL C.O., KEEFE E.B. Ganciclovir treatment of hepatitis B virus infection in liver transplant recipients. Hepatology, 1996, 23 : 1-7.
32. TERRAULT N.A, WRIGHT T.L. Preemptive therapy against hepatitis B virus infection. In : RIZZETTO M, PURCELL R.H., GERIN J.L., VERME G, (Eds). Viral hepatitis and liver disease. In : Viral hepatitis and liver disease ; Minerva Medica, 1997 : 829-31.
33. KRUGER M., TILLMAN H.L., TRAUTWEIN C.H. Famciclovir treatment of hepatitis B virus recurrence after liver tranplantation : a pilot study. Liver Transplant Surg., 1996, 2 : 253-62.
34. GRELLIER L., MULTIMER D., AHMED M., BROWN D., BURROUGHS A.K., ROLLES K., MCMASTER P., BERANEK P., KENNEDY F., KIBBLER H., MCPHILLIPS P., ELIAS E., DUSHEIKO G. Lamivudine prophylaxis against reinfection in liver tranplantation for hepatitis B cirrhosis. Lancet, 1996, 348 : 1212-15.
35. BAIN V.G., KNETEMAN N.M., MA M.M., GUTFREUND K., SHAPIRO J.A., FISCHER K., TIPPLES G. Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. Transplantation. 1996, 62 : 1456-1462.
36. MARKOWITZ J.S., MARTIN P., CONRAD A.J., MARKMANN J.F., SEU P., YERSIZ H., GROSS J.A., SCHMIDT P., PAKRASI A., ARTINIAN L., MURRAY N.G.B., IMAGAWA D.K., HOLT C., GOLDSTEIN L.I., STRIBLING R., BUSURTIL R. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology, 1998, 28 : 585-589.
37. DEBERNARDI W., MARZANO A., SMEDILE A., BRUNETTO M.R., TORRANI-CERENZIA M., GHISETTI V., SALIZZONI M., RIZZETTO M. Antiviral Prophylaxis with nuclcoside analogues can reduce the hepatitis B recurrence after liver transplantation. J. Hepatol, 1997, 26 : 145.
38. LING R., MUTIMER D., AHMED M., BOXALL E.H., ELLIAS E., DUSHEIKO G.M., HARRISON T.J. Selection of Mutations in the Hepatitis B virus Polymerase During Therapy of Transplant Recipients with Lamivudine. Hepatology, 1996, 24 : 711-713.
39. BARTHOLOMEW M., JANSEN R., JEFFERS L., JEFFERS L.J., REDDY K.R., JOHNSON L.C., BUNZENDAHL H., CONDREAY L.D., TZAKIS A.G., SCHIFF E.R., BROWN N.A. Hepatitis B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet, 1997, 349 : 20-22.
40. GU Z. Identification of a mutation at codon 65 in the IKKK motif of reverse transciptase that encodes human immunodeficiency virus resistance to 2', 3-dideoxycytidine and 2′3′ dideoxy-3-thiacytidine. Antimicrob Agents Chemother, 1994, 38 : 275-281.
41. SHALM S.W. Clinical implications of lamivudine resistance by HBV. Lancet, 1997, 349 : 3-4.
42. MARZANO A., DEBERNARDI-VENON W., CONDREAY L., RIZZETTO M. Efficacy lamivudine re-treatment in a patient with HBV recurrence after liver trasnplantation and HBV-DNA breakthrough during the first treatment. Transplantation, 1998, 65 : 1499-1450.
43. XIONG X. Lack of cross-resistance to PMEA for human hepatitis B DNA polymerase wich express lamivudine resistance codons. Hepatology, 1997, 26 : 413
44. ASCHER N.L., LAKE J.R., EMOND J., ROBERTS J. Liver transplantation for Hepatitis C virus-related cirrhosis. Hepatology, 1994, 20 : 24S : 27S.
45. FÉRAY C., GIGOU M., SAMUEL D., PARADIS V., WILBER J., DAVID M.F., URDEA M., REYNES M., BRECHOT C., BISMUTH H. The course of hepatitis C virus infection after liver transplantation. Hepatology, 1994, 20 : 1137-1143.
46. BELLI L.S., CACCAMO L., MAZZAFERRO V., SILINI E., ALBERTI A., MELADA E., REGALIA E., GRIDELLI B., RUBINO A., GENNARI L. Milan multicenter experience in liver transplantation for hepatitis C-related cirrhosis : report of 105 cases. Transplantation Proceedings, 1994, 26 : 3582-3584.
47. MARZANO A., SMEDILE A., ABATE M., OTTOBRELLI A., BRUNETTO M., NEGRO F., FARCI P., DURAZZO M., DAVID E., LAGGET M., VERME G., BONINO F., RIZZETTO M. Hepatitis type C after ortothopic liver transplantation : reinfection and disease recurrence. J. Hepatol., 1994, 21 : 961-964.
48. LAVEZZO B., OTTOBRELLI A., SMEDILE A., RIZZETTO M. Factors associated with cholestatic hepatitis after liver transplantation for cirrhosis type C (HCV). Ital. J. Gastroenterol., 1995, 27(8) : 467-68.
49. BOKER K.H., DALLEY G., BAHR M.J., MASCHEK H., TILLMANN H.L., TRAUTWEIN C., OLDHAVER K., BODE U., PICHLMAYER R., MANNS M.P. Long-term ouctome of hepatitis C virus infection after liver transplantation. Hepatology, 1997, 25 : 203-210.
50. HOOFNAGLE J.H. Liver transplantation for viral hepatitis. In : RIZZETTO M., PURCELL R.H., GERIN J.L., VERME G. (Eds). Viral hepatitis and liver disease. Minerva Medica, Turin, 1997 : 813-819.
51. MAZZAFERRO V., REGALIA E., PULVIRENTI A., PALAZZO U., ANDREOLA S., PASQUALI M., BARATTI D. Effect of interferon and ribavirin prophylaxis after liver transplantation in HCV RNA positive patients. Hepatology, 1995, 22 : 287.
52. FERAY C., SAMUEL D., GIGOU M., PARADIS V., DAVID M.F., LEMONNIER C., REYNES M, BISMUTH H. An open trial of interferon-(recombinant for hepatitis C after liver transplantation. Hepatology, 1995, 22 : 1084-1089.
53. CATTRAL, M.S., KRAJDEN M., WANLESS I.R., REZIG M., CAMERO R., GREIG P.D., CHUNG S.W., LEV G. A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation, 1996, 61 : 1483-1488.
54. GANE E.J., SU-KONG L., RIORDAN S., PORTMANN B.C., LAU J.Y.N., NAOUMOV N.V., WILLIAMS R. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation. Hepatology, 1998, 27 : 1403-1407.
55. BIZOLLON T., PALAZZO U., DUCERF C., CHEVALLIER M., ELLIOTT M., BAULIEUX J., POUYET M., TREPO C. Pilot study of combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation. Hepatology, 1997, 26 : 500-504.
56. SMEDILE A., CASEY J.L., COTE P.J., DURAZZO M., LAVEZZO B., PURCELL R.H., RIZZETTO M., GERIN J.L. Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope. Hepatology, 1998, 27 : 1723-1729.
57. SAMUEL D., ZIGNEGO A.L., REYNES M., FERAY C., ARUNADEN J.L., DAVID M.F., GIGOU M., BISMUTH A., MATHIEU D., GENTILINI P. Long -term clinical and virologic outcome after liver transplantation for cirrhosis due to chronic delta hepatitis. Hepatology, 1995, 21 : 333-39.
58. FAGIUOLI S., LEANDRO G., BELLATI G., GASBARRINI A., RAPACCINI G.L., POMPILI M., RENDINA M., DENOTARIIS S., FRANCAVILLA A., GASBARRINI G., IDEO G., NACCARATO R. Liver transplantation in Italy : preliminary 10-year report. Ital. J. Gastroenterology, 1996, 28 : 343-350.